Association between chromogranin b gene polymorphisms and schizophrenia in the japanese population

Biological Psychiatry

Volumn 56, Issue 1, 2004, Pages 10-17

  Iijima, Yoshimi ^a   Inada, Toshiya ^b   Ohtsuki, Tsuyuka ^c   Senoo, Hisashi ^d   Nakatani, Masaki ^d   Arinami, Tadao ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Institute of Social Welfare   (Japan)

Author keywords

association study; chromogranin B; neuropeptide; Schizophrenia

Indexed keywords

ACID PROTEIN; CHROMOGRANIN B; SECRETORY PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; ENDOCRINE CELL; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; JAPAN; MALE; MICROSATELLITE MARKER; NERVE CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANIMALS; CASE-CONTROL STUDIES; CATTLE; CHROMOGRANIN B; CHROMOGRANINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; CONSENSUS SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MICE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RATS; REFERENCE VALUES; SCHIZOPHRENIA; SEQUENCE DELETION;

EID: 3042565404     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.03.012     Document Type: Article

References (26)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev:1987;American Psychiatric Association, Washington, DC
2. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry. 7:2002;405-411
3. Bauer J.W., Fischer-Colbrie R. Primary structure of bovine chromogranin B deduced from cDNA sequence. Biochim Biophys Acta. 1089:1991;124-126
4. Benedum U.M., Lamouroux A., Konecki D.S., Rosa P., Hille A., Baeuerle P.A., et al. The primary structure of human secretogranin I (chromogranin B) Comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO J. 6:1987;1203-1211
5. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 361:2003;865-872
6. Saitoh T., Oizumi T., Tominaga M., Nakamura T., Daimon M., Ji G. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem Biophys Res Commun. 302:2003;751-758
7. Dudbridge F., Koeleman B.P., Todd J.A., Clayton D.G. Unbiased application of the transmission/disequilibrium test to multilocus haplotypes. Am J Hum Genet. 66:2000;2009-2012
8. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 48:1992;361-372
9. Hovatta I., Lichtermann D., Juvonen H., Suvisaari J., Terwilliger J.D., Arajarvi R., et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol Psychiatry. 3:1998;452-457
10. Ishiwata M., Bundo M., Kasahara T., Kusumi I., et al., Kakiuchi C., Iwamoto K. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet. 35:2003;171-175
11. Kitao Y., Inada T., Arinami T., Hirotsu C., Aoki S., Iijima Y., et al. A contribution to genome-wide association studies Search for susceptibility loci for schizophrenia using DNA microsatellite markers on chromosomes 19, 20, 21 and 22. Psychiatr Genet. 10:2000;139-143
12. Landen M., Grenfeldt B., Davidsson P., Stridsberg M., Regland B., Gottfries C.G., et al. Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia. Eur Neuropsychopharmacol. 9:1999;311-315
13. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II Schizophrenia. Am J Hum Genet. 73:2003;34-48
14. Little J., Bradley L., Bray M.S., Clyne M., Dorman J., Ellsworth D.L., et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 156:2002;300-310
15. Miller C., Kirchmair R., Troger J., Saria A., Fleischhacker W.W., Fischer-Colbrie R., et al. CSF of neuroleptic-naive first-episode schizophrenic patients Levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). Biol Psychiatry. 39:1996;911-918
16. Moises H.W., Yang L., Kristbjarnarson H., Wiese C., Byerley W., Macciardi F., et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet. 11:1995;321-324
17. Nowakowski C., Kaufmann W.A., Adlassnig C., Maier H., Salimi K., Jellinger K.A., et al. Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia. Schizophr Res. 58:2002;43-53
18. Ozawa H., Takata K. The granin family - Its role in sorting and secretory granule formation. Cell Struct Funct. 20:1995;415-420
19. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The structured clinical interview for DSM-III-R (SCID). I History, rationale, and description. Arch Gen Psychiatry. 49:1992;624-629
20. So S.H., Jeon S.H., Ehrlich B.E., Yoo S.H., Thrower E.C., Choe C.U. A functional interaction between chromogranin B and the inositol 1, 4, 5-trisphosphate receptor/Ca2+ channel. J Biol Chem. 278:2003;49699-49706
21. van Kammen D.P., Agren H., Yao J.K., O'Connor D.T., Gurklis J., Peters J.L. Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. Am J Psychiatry. 151:1994;379-384
22. van Kammen D.P., O'Connor D.T., Neylan T.C., Mouton A., Gurklis J.A., Gilbertson M.W., et al. CSF chromogranin A-like immunoreactivity in schizophrenia Relationships with REM latency and slow wave sleep. Psychiatry Res. 42:1992;53-63
23. van Kammen D.P., Peters J., Yao J., Neylan T., Beuger M., Pontius E., et al. CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships. Schizophr Res. 6:1991;31-39
24. Winkler H., Fischer-Colbrie R. The chromogranins A and B The first 25 years and future perspectives. Neuroscience. 49:1992;497-528
25. Kang M.K., Huh Y.H., Lee C.S., Shim C.S., Yoo S.H., You S.H. Localization of the secretory granule marker protein chromogranin B in the nucleus. Potential role in transcription control. J Biol Chem. 277:2002;16011-16021
26. Zhang B., Tan Z., Zhang C., Shi Y., Lin Z., Gu N., et al. Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population. Neurosci Lett. 323:2002;229-233